Your browser doesn't support javascript.
loading
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer.
Zhou, Yuzhen; Börcsök, Judit; Adib, Elio; Kamran, Sophia C; Neil, Alexander J; Stawiski, Konrad; Freeman, Dory; Stormoen, Dag Rune; Sztupinszki, Zsofia; Samant, Amruta; Nassar, Amin; Bekele, Raie T; Hanlon, Timothy; Valentine, Henkel; Epstein, Ilana; Sharma, Bijaya; Felt, Kristen; Abbosh, Philip; Wu, Chin-Lee; Efstathiou, Jason A; Miyamoto, David T; Anderson, William; Szallasi, Zoltan; Mouw, Kent W.
Afiliação
  • Zhou Y; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Börcsök J; Danish Cancer Institute, Copenhagen, Denmark.
  • Adib E; Biotech Research & Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Kamran SC; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Neil AJ; Harvard Medical School, Boston, MA, USA.
  • Stawiski K; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Freeman D; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Stormoen DR; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Sztupinszki Z; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Samant A; Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
  • Nassar A; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bekele RT; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hanlon T; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Valentine H; Danish Cancer Institute, Copenhagen, Denmark.
  • Epstein I; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
  • Sharma B; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Felt K; Department of Hematology/Oncology, Yale New Haven Hospital, New Haven, CT, USA.
  • Abbosh P; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wu CL; Harvard Medical School, Boston, MA, USA.
  • Efstathiou JA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Miyamoto DT; Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Anderson W; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Szallasi Z; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Mouw KW; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Sci Adv ; 9(47): eadg2263, 2023 11 24.
Article em En | MEDLINE | ID: mdl-37992168
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Ataxia Telangiectasia / Antineoplásicos Limite: Humans Idioma: En Revista: Sci Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Ataxia Telangiectasia / Antineoplásicos Limite: Humans Idioma: En Revista: Sci Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos